CSS
RLAY icon

Cubist Systematic Strategies’s Relay Therapeutics RLAY Stock Holding History

Cubist Systematic Strategies’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-317,211
Closed -$1.31M – 3413
2024
Q4 		$1.31M Sell
317,211
-42,121
-12% -$229K 0.01% 1650
2024
Q3 		$2.54M Buy
+359,332
New +$2.68M 0.02% 1276
2024
Q2 		– Sell
-1,229
Closed -$10.2K – 3853
2024
Q1 		$10.2K Buy
+1,229
New +$12K ﹤0.01% 3511
2023
Q4 		– Sell
-279,115
Closed -$2.35M – 4026
2023
Q3 		$2.35M Buy
279,115
+101,612
+57% +$1.09M 0.02% 1253
2023
Q2 		$2.23M Buy
+177,503
New +$2.21M 0.01% 1406
2023
Q1 		– Sell
-62,560
Closed -$935K – 4338
2022
Q4 		$935K Buy
62,560
+10,626
+20% +$203K 0.01% 2509
2022
Q3 		$1.16M Sell
51,934
-7,286
-12% -$160K 0.01% 2498
2022
Q2 		$992K Buy
59,220
+41,922
+242% +$898K 0.01% 2493
2022
Q1 		$518K Buy
17,298
+9,653
+126% +$234K ﹤0.01% 2517
2021
Q4 		$235K Sell
7,645
-58,673
-88% -$1.85M ﹤0.01% 2947
2021
Q3 		$2.09M Buy
66,318
+38,385
+137% +$1.29M 0.03% 981
2021
Q2 		$1.02M Sell
27,933
-854
-3% -$28.1K 0.01% 1561
2021
Q1 		$995K Buy
28,787
+12,387
+76% +$538K 0.01% 1539
2020
Q4 		$682K Buy
16,400
+1,881
+13% +$85K 0.01% 1606
2020
Q3 		$618K Buy
+14,519
New +$554K 0.01% 1614

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Cubist Systematic Strategies's RLAY Position: Q1 2025 in Review

Cubist Systematic Strategies sold out of Relay Therapeutics (RLAY) in Q1 2025, closing a stake of 317,211 shares — an estimated $1.31M sold.

Cubist Systematic Strategies first reported a position in RLAY in Q3 2020 and held it in 15 quarters. The position peaked at $2.54M in Q3 2024. 207 funds tracked by Wall St. Rank hold RLAY as of Q1 2025.

  • Cubist Systematic Strategies reported no remaining Relay Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 317,211 Relay Therapeutics shares in Q1 2025, an estimated $1.31M.
  • Cubist Systematic Strategies first reported a position in Relay Therapeutics in Q3 2020 and held it in 15 quarters.
  • Cubist Systematic Strategies's Relay Therapeutics position peaked at $2.54M in Q3 2024.
  • 207 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2025.

Based on Cubist Systematic Strategies's 13F filing for Q1 2025, filed 15 May 2025.